Lv12
13 积分 2021-07-05 加入
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
2小时前
已完结
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials
22小时前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
22小时前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
22小时前
已完结
Gastric cancer
1天前
已完结
Histological and biomarker landscape of Claudin18.2-positive gastric and gastroesophageal junction cancers: a study of 937 cases
10天前
已完结
The Landscape of Clinical Trials for Claudin18.2-Positive Gastric Cancer
10天前
已完结
Cholecystectomy-related gut microbiota dysbiosis exacerbates colorectal tumorigenesis
13天前
已完结
Gastric cancer
1个月前
已完结
Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings
2个月前
已完结
皖公网安备34019202002308
